Skip to content

Technology
Clinical Data
Pipeline
About
Media
Contact

Author: David Horn

News

24/04/2020

BetaGlue® Technologies announces new Board of Directors

Technology
Clinical Data
Pipeline
About
Contact

Legal headquarters: Via della Moscova, 3 – 20121 Milan, Italy

YntraDose® is currently under development and is not approved for human use or sale.

© 2025 BetaGlue Therapeutics SpA. All rights reserved | TAX ID number: 06496571214

Privacy Policy
Cookie Policy
Corporate Governance